Here, we found that SARS-CoV-2 infection reduces YAP target gene expression in human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and lung epithelial cells of COVID-19 patients. This evidence concerns the gene YAP1 and COVID-19.